James Larkin is an Oncology researcher affiliated with Royal Marsden NHS Foundation Trust. OpenAlex indexes 1,132 publications with 129,137 citations (h-index 127); ClinicalTrials.gov lists 7 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
7 registered studies on ClinicalTrials.gov matched to this name. Itemized trial rows, roles and sponsors are part of the full profile. Why? →
Payments and prescribing
Payments from pharmaceutical companies to health professionals in this country are disclosed under the EFPIA Disclosure Code, on company or national websites. Named disclosure needs the professional's consent and stays online for three years. It is not published as reusable data, so it is not shown here. About the EFPIA Code
Prescribing by individual physicians is not published.
Similar KOLs
Other experts from the same institution or the same specialty.
Johann Sebastian De Bono
Royal Marsden NHS Foundation Trust
David Cunningham
Royal Marsden NHS Foundation Trust
Rosalind A. Eeles
Royal Marsden NHS Foundation Trust
Nicholas C. Turner
Royal Marsden NHS Foundation Trust
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”